Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Proud Boys member arrested
'I am a corrupt politician'
Another Taylor Swift surge?
Teen struck by lightning, dies
'I feel pretty good'
'Bed poverty' in UK
Reunite after 10-year feud
'I'm incredibly sorry'
Human trafficking arrest
2 dead after plane crash
Not competent for execution
Calif. minimum wage raised
Bakhtiari on injured reserve
Complete winners list
Tributes pour in for Gambon
New song collaboration
Set for hip surgery
Remains found in 1996 ID'd
Musk livestreams border
Get into heated exchange
Nia Long slams Celtics
Orioles clinch AL East title
Man wins $8.75M lottery
Expecting first baby
Debate draws 9.5M viewers
Biopic series in development
Gravy settles with Astley
Deadly blast at Pak rally
Settles rape lawsuit
Tosses helmet into stands
No govt. shutdown for parks
Sued for racial harassment
No Fat Bear Week?
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
45,600 results
1don MSN
This $6-Per-Share Cancer Research Startup Discovered An Oddly Simple Solution To Solid Tumors, Achieving A 100% Remission Rate
Cholera claimed the lives of thousands in North America for decades until major cities cleaned their pipes. Scurvy killed ...
MedPage Today27d
Cancer Patients More Likely to Die During COVID Pandemic
Share on Facebook. Opens in a new tab or window Share on Twitter. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Cancer patients experienced significantly higher ...
Science Daily1d
Colon Cancer News
Sep. 12, 2023 — Scientists discovered a previously unknown interaction between proteins that is responsible for supplying energy to tumor cells and could hold significant implications for the ...
Daily Mail24d
The first patients to be have their 'incurable' cancer treated by new personalised MRNA vaccines that could revolutionise cancer care
At this time last year, Adrian Taylor was given a devastating prognosis: he had incurable cancer in his lungs and without treatment there was a 100 per cent chance he'd die from it, potentially ...
3d
Young cancer survivors in Europe get increased post-cure help
As medical advances in oncology enable more patients to beat tumors, greater attention is being paid to secondary effects ...
Science Daily3d
Ovarian Cancer News
Sep. 21, 2023 — A study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development can benefit patients with late-stage, drug ...
Medscape3d
The Benefits of Psychosocial Interventions for Cancer Patients Undergoing Radiotherapy
Background: Many patients with cancer experience depression and anxiety, and an associated decrease in quality of life (QOL) during radiation therapy (RT). The main objective of the study was to ...
The American Journal of Managed Care16d
Patients With NSCLC Describe Experiences of Symptoms on Daily Life
Patients with advanced or metastatic non–small cell lung cancer (NSCLC) were able to specify a 1-point threshold when describing meaningful symptom change, for better or worse, that helped ...
Medscape27d
Management of Anemia in Cancer Patients
Table 2. Recommendations for the use of erythropoiesis-stimulating agents in patients with nonhematological malignancies. Organization Anemia related to chemotherapy Untreated patients Patients ...
Business Wire20d
Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer
ROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today announced its participation in the upcoming International Association for the Study of Lung Cancer (IASLC) 2023 World Conference ...
Business Wire17d
OSE Immunotherapeutics Announces: Positive Phase 3 Data from its Cancer Vaccine in Lung Cancer Patients with Resistance to Previous Immunotherapy Published in Annals of Oncology
NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced the peer-reviewed publication in Annals of Oncology* of the ...
Seeking Alpha21d
S&P Global announces proposed offering of senior notes
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices